A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Evaluation of Yervoy in Combination With Adoptive T Cell Transfer for Metastatic Melanoma Patients (NCT01988077) | Sheba Medical Center | 2013-10-01 |
Track A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response automatically
Every clearance here is in the API, with alerts when new ones post.